RxDoctor Payments Data

Alice Chen

Hematology & Oncology · Bethesda, MDNPI 1518079805

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,640 of the $6,928 with a category attached, or 95.8%. Genentech, Inc. accounts for 95.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $6,640 and has fallen 98.1% since, to $125 in 2025.

$6,928in general payments, 2019–2025

Across 3 payments — averaging $2309.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$7K
  • Medtronic$163
  • Biogen$125
$3,435,993in research payments, 2019–2025

Across 10 payments — averaging $343,599 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim$2.4M
  • Pfizer$809K
  • AstraZeneca$91K
  • Novartis$87K

What the payments were for

  • Consulting fees$6,64096%
  • Food & beverage$2884%

General payments by program year

19
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.1$6,640
Medtronic1$163
Biogen1$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,928 in reported general payments places this provider in the 65th percentile of 242 hematology & oncology providers in Maryland.

See all hematology & oncology providers in Maryland

Other hematology & oncology in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →